{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T18:31:11Z","timestamp":1773685871172,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007338","name":"All-India Institute of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007338","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Journal of Medical Microbiology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ijmmb.2026.101051","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T07:35:12Z","timestamp":1768548912000},"page":"101051","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["\u201cIn vitro evaluation of sulbactam combination therapies for Acinetobacter baumannii\u201d"],"prefix":"10.1016","volume":"60","author":[{"given":"Karthick Kumar","family":"Vaitheeswaran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8797-5286","authenticated-orcid":false,"given":"Seema","family":"Sood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manish","family":"Soneja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Animesh","family":"Ray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shivam","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arti","family":"Kapil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naveet","family":"Wig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10459","key":"10.1016\/j.ijmmb.2026.101051_bib1","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","article-title":"Global burden of bacterial antimicrobial resistance 1990\u20132021: a systematic analysis with forecasts to 2050","volume":"404","author":"Naghavi","year":"2024","journal-title":"Lancet"},{"issue":"Suppl 1","key":"10.1016\/j.ijmmb.2026.101051_bib2","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1093\/ofid\/ofy293","article-title":"Antimicrobial susceptibility of acinetobacter calcoaceticus-Acinetobacter baumannii Complex and Stenotrophomonas maltophilia Clinical Isolates: results from the SENTRY Antimicrobial Surveillance Program (1997-2016)","volume":"6","author":"Gales","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ijmmb.2026.101051_bib3","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jgar.2022.08.002","article-title":"Global update on the in vitro activity of tigecycline and comparators against isolates of Acinetobacter baumannii and rates of resistant phenotypes (2016-2018)","volume":"31","author":"Seifert","year":"2022","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.ijmmb.2026.101051_bib4","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jgar.2024.03.020","article-title":"Global trends in carbapenem- and difficult-to-treat-resistance among World Health Organization priority bacterial pathogens: ATLAS surveillance program 2018-2022","volume":"37","author":"Wise","year":"2024","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.ijmmb.2026.101051_bib5","unstructured":"1725536060_annual_report_2023.pdf [Internet]. [cited 2025 May 10]. Available from: https:\/\/www.icmr.gov.in\/icmrobject\/uploads\/Documents\/1725536060_annual_report_2023.pdf."},{"issue":"12","key":"10.1016\/j.ijmmb.2026.101051_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0311124","article-title":"Geographical mapping and temporal trends of Acinetobacter baumannii carbapenem resistance: a comprehensive meta-analysis","volume":"19","author":"Beig","year":"2024","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ijmmb.2026.101051_bib7","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1093\/cid\/ciad556","article-title":"Clinical outcomes and bacterial characteristics of carbapenem-resistant Acinetobacter baumannii among patients from different global regions","volume":"78","author":"Wang","year":"2024","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.ijmmb.2026.101051_bib8","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4103\/ijmm.IJMM_19_492","article-title":"Mortality from acinetobacter infections as compared to other infections among critically ill patients in South India: a prospective cohort study","volume":"38","author":"John","year":"2020","journal-title":"Indian J Med Microbiol"},{"key":"10.1016\/j.ijmmb.2026.101051_bib9","doi-asserted-by":"crossref","first-page":"ciae403","DOI":"10.1093\/cid\/ciae403","article-title":"Infectious diseases Society of America 2024 guidance on the treatment of antimicrobial-resistant gram-negative infections","volume":"78","author":"Tamma","year":"2024","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.ijmmb.2026.101051_bib10","doi-asserted-by":"crossref","first-page":"177S","DOI":"10.1378\/chest.117.4_suppl_2.177S","article-title":"Evidence-Based assessment of diagnostic tests for Ventilator-Associated Pneumonia: executive Summary","volume":"117","author":"Grossman","year":"2000","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.ijmmb.2026.101051_bib11","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1179\/1973947812Y.0000000029","article-title":"In vitro effects of sulbactam combinations with different antibiotic groups against clinical Acinetobacter baumannii isolates","volume":"24","author":"Deveci","year":"2012","journal-title":"J Chemother Florence Italy"},{"issue":"5","key":"10.1016\/j.ijmmb.2026.101051_bib12","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.ijantimicag.2005.01.011","article-title":"Comprehensive in vitro evaluation of cefepime combined with aztreonam or ampicillin\/sulbactam against multi-drug resistant Pseudomonas aeruginosa and Acinetobacter spp","volume":"25","author":"Sader","year":"2005","journal-title":"Int J Antimicrob Agents"},{"issue":"5","key":"10.1016\/j.ijmmb.2026.101051_bib13","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.ijantimicag.2006.08.008","article-title":"In vitro activity of cefepime combined with sulbactam against clinical isolates of carbapenem-resistant Acinetobacter spp","volume":"28","author":"Tong","year":"2006","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"10.1016\/j.ijmmb.2026.101051_bib14","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.diagmicrobio.2005.03.003","article-title":"In vitro synergy test of meropenem and sulbactam against clinical isolates of Acinetobacter baumannii","volume":"52","author":"Kiffer","year":"2005","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"4","key":"10.1016\/j.ijmmb.2026.101051_bib15","first-page":"24","article-title":"A prospective evaluation of synergistic effect of sulbactam and tazobactam combination with meropenem or colistin against multidrug resistant Acinetobacter baumannii","volume":"15","author":"Marie","year":"2015","journal-title":"Bosn J Basic Med Sci"},{"issue":"6","key":"10.1016\/j.ijmmb.2026.101051_bib16","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1093\/jac\/dkac102","article-title":"A carbapenem-resistant Acinetobacter baumannii outbreak associated with a polymyxin shortage during the COVID pandemic: an in vitro and biofilm analysis of synergy between meropenem, gentamicin and sulbactam","volume":"77","author":"Chaiben","year":"2022","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"10.1016\/j.ijmmb.2026.101051_bib17","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/1120009X.2016.1143261","article-title":"Determination of synergy between sulbactam, meropenem and colistin in carbapenem-resistant Klebsiella pneumoniae and Acinetobacter baumannii isolates and correlation with the molecular mechanism of resistance","volume":"28","author":"Laishram","year":"2016","journal-title":"J Chemother Florence Italy"},{"issue":"4","key":"10.1016\/j.ijmmb.2026.101051_bib18","doi-asserted-by":"crossref","first-page":"445","DOI":"10.4103\/ijmm.IJMM_17_189","article-title":"An update on technical, interpretative and clinical relevance of antimicrobial synergy testing methodologies","volume":"35","author":"Laishram","year":"2017","journal-title":"Indian J Med Microbiol"},{"issue":"4","key":"10.1016\/j.ijmmb.2026.101051_bib19","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1590\/S1517-838246420140101","article-title":"Synergistic effects of sulbactam in multi-drug-resistant Acinetobacter baumannii","volume":"46","author":"Temocin","year":"2015","journal-title":"Braz J Microbiol Publ Braz Soc Microbiol"},{"key":"10.1016\/j.ijmmb.2026.101051_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2019.05.018","article-title":"Population pharmacokinetics and Monte Carlo simulations of sulbactam to optimize dosage regimens in patients with ventilator-associated pneumonia caused by Acinetobacter baumannii","volume":"136","author":"Jaruratanasirikul","year":"2019","journal-title":"Eur J Pharm Sci"},{"issue":"6","key":"10.1016\/j.ijmmb.2026.101051_bib24","doi-asserted-by":"crossref","DOI":"10.1093\/jacamr\/dlae203","article-title":"Pharmacokinetic\/pharmacodynamic analysis of sulbactam against Acinetobacter baumannii pneumonia: establishing in vivo efficacy targets in the epithelial lining fluid","volume":"6","author":"Abouelhassan","year":"2024","journal-title":"JAC Antimicrob Resist"},{"issue":"12","key":"10.1016\/j.ijmmb.2026.101051_bib25","first-page":"3291","article-title":"New pharmacokinetic\/pharmacodynamic studies of systemically administered colistin against Pseudomonas aeruginosa and Acinetobacter baumannii in mouse thigh and lung infection models: smaller response in lung infection","volume":"70","author":"Cheah","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijmmb.2026.101051_bib26","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jgar.2020.08.021","volume":"24","author":"Liu","year":"2021","journal-title":"J Glob Antimicrob Resist"},{"issue":"1","key":"10.1016\/j.ijmmb.2026.101051_bib27","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1186\/s13054-017-1916-6","article-title":"Antimicrobials for the treatment of drug-resistant Acinetobacter baumannii pneumonia in critically ill patients: a systemic review and Bayesian network meta-analysis","volume":"21","author":"Jung","year":"2017","journal-title":"Crit Care"},{"issue":"2","key":"10.1016\/j.ijmmb.2026.101051_bib28","doi-asserted-by":"crossref","first-page":"S166","DOI":"10.1093\/cid\/ciad109","article-title":"Global epidemiology and mechanisms of resistance of acinetobacter baumannii-calcoaceticus complex","volume":"76","author":"Castanheira","year":"2023","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"issue":"3","key":"10.1016\/j.ijmmb.2026.101051_bib29","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s00284-025-04097-1","article-title":"Increasing burden of antibiotic resistance in India due to Co-existence of multiple classes of Carbapenem and different aminoglycoside resistance genes in clinical isolates of Acinetobacter baumannii","volume":"82","author":"Amar","year":"2025","journal-title":"Curr Microbiol"},{"issue":"9","key":"10.1016\/j.ijmmb.2026.101051_bib30","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1093\/jac\/dkae229","article-title":"Defining optimal sulbactam regimens for treatment of Acinetobacter baumannii pneumonia and impact of blaOXA-23 on efficacy","volume":"79","author":"Abouelhassan","year":"2024","journal-title":"J Antimicrob Chemother"}],"container-title":["Indian Journal of Medical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0255085726000095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0255085726000095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T17:38:26Z","timestamp":1773682706000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0255085726000095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":27,"alternative-id":["S0255085726000095"],"URL":"https:\/\/doi.org\/10.1016\/j.ijmmb.2026.101051","relation":{},"ISSN":["0255-0857"],"issn-type":[{"value":"0255-0857","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u201cIn vitro evaluation of sulbactam combination therapies for Acinetobacter baumannii\u201d","name":"articletitle","label":"Article Title"},{"value":"Indian Journal of Medical Microbiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijmmb.2026.101051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Indian Association of Medical Microbiologists. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101051"}}